Navigation Links
Are PET Scans Beneficial During Cancer Diagnosis, Staging and Monitoring?
Date:8/13/2008

PORTLAND, Ore., Aug. 13 /PRNewswire/ -- Today positron emission tomography (PET) scanning is emerging as an increasingly helpful oncology tool for diagnosis, staging and monitoring. It is a computer-based, low-resolution imaging technology emitting a radioactive tracer to localize tumors. The radioactive positron tracer gathers in abnormal tissue. As a result, the malignant tissue stands out from normal tissue and appears as a "hot spot."

The use of multiple imaging technologies is growing in importance for the diagnosis, staging and monitoring treatment for many types of cancers. Once an oncologist diagnoses a patient with cancer, current standards of care require the doctor to decide which stage a cancer patient has reached. Before completing a treatment plan, the oncologist must decide whether the malignancy is localized, attacking nearby tissues or spreading to other parts of the body.

"After the staging step, oncologists often monitor a patient's cancer treatment for effectiveness or reappearance of a tumor," said Dr. Skip Freedman, executive medical director at AllMed Healthcare Management, a leading Independent Review Organization (IRO). http://www.allmedmd.com

According to Freedman, an oncologist usually combines a PET scan with computed tomography (CT) to capture higher resolution pictures of a patient's tissue. Because the PET images are low-resolution, oncologists combine the two to increase the image resolution and clarity of any "hot spots" showing up in the PET scan.

However, scanning is expensive, about $1,800 for PET and $2,100 for a combined PET and CT scan. Both also emit high doses of radiation, about 150 chest x-ray equivalents (CXREs) for a PET scan and 350 to 550 CXREs for combined PET and CT scans. One CXRE equals the radiation a patient receives from one X-ray. So there are tradeoffs for both doctors and patients to consider.

"For many tumors, PET scans are only a slightly more effective diagnostic tool in terms of sensitivity and specificity than CT scans or MRIs," said Freedman. "So their use is being researched to discover if and how much they may improve patient outcomes."

The Center for Medicare and Medicaid Services is one agency currently studying how PET scans might change oncology treatment decisions and improve patient outcomes. The agency currently approves PET scans for several types of cancer including colorectal, lymphoma, head and neck, pancreatic, testicular and several others.

For more information on leading-edge treatments and their medical necessity, check out http://www.allmedmd.com/peerpoints/cuttingedge/cutting_edge_email.htm. Or view AllMed's Webinar, "Cancer Testing and Treatment: New Questions, New Answers" at http://www.allmedmd.com/resources/downloads/webinar4_download.html (requires registration). To find out more about the medical review services that IROs offer, go to AllMed's Website at http://www.allmedmd.com.


'/>"/>
SOURCE AllMed Healthcare Management
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. PET Scans Show Gene Therapy Normalizes Brain Function in Parkinsons Patients
2. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
3. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
4. Study Finds Taxus(R) Drug-Eluting Stent Beneficial in Treatment of Large Vessels
5. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
6. Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia
7. United States, Canada and Mexico Agree to Mutual Assistance During Public Health Emergencies
8. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
9. Researcher Investigates Disparities in Doctor-Patient Information Exchange During Clinical Trial Offers
10. Bone Mineral Content Continues to Increase in Obese Adolescents During Weight Loss
11. Leukemia Therapy With Imatinib During Pregnancy May Cause Infant Abnormalities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... YORK , Feb. 24, 2017 ... Monteverde & Associates PC , a boutique securities firm ... New York City , announces that a class ... Massachusetts  against Inotek Pharmaceuticals Corporation ... of the Company,s securities between July 23, 2015 and December ...
(Date:2/24/2017)... ITL Limited, ( ASX: ITD ), ... für das zum 31. Dezember 2016 endende Halbjahr ... vorlegen zu können. Eine vollständige Präsentation „Ergebnisse von ... Sie hier . Glanzpunkte ... 2015: 1,04 Millionen USD; +104 %) Gewinn je ...
(Date:2/24/2017)... YORK , Feb. 23, 2017  This report ... Thousand by the following Products: Intermediates, ... in the report include Pharmaceuticals, and Agrochemicals. The report ... Japan , Europe , and ... for the period 2015 through 2022. Also, a six-year ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... The International Association of Eating Disorders Professionals (iaedp) ... You See” body image mannequin art competition. Selected from 15 submissions from around the ... revealed at the 31st annual iaedp Symposium, March 22 – 26 in Las Vegas. ...
(Date:2/24/2017)... ... February 24, 2017 , ... Castle Farms, the celebrated ... Giveaway, with the winning couple announced on Feb. 14, 2017, on Facebook. The ... local vendors: A Matter of Taste, Ryan Rousseau Enterprises, A Touch of Spring ...
(Date:2/23/2017)... ... 23, 2017 , ... Rare Disease Report®, which is the ... Rare Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) on ... weekly e-newsletter and quarterly publication, will be conducting interviews with patients and advocates ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... for the National Institute for Health and Care Excellence (NICE) framework. ... the National Health Service (NHS) to search, order and purchase medical and healthcare-related ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... Phoenix, announced today that it will soon begin franchising throughout the U.S. starting ... mission to help bring the practice of meditation mainstream. Current Meditation will be ...
Breaking Medicine News(10 mins):